Product Name: A53-B/A2 (IgG2a)
Background: Cytokeratins are a subfamily of intermediate filaments and characterized by remarkable biochemical diversity. Cytokeratins are represented in epithelial tissues by at least 20 different polypeptides, molecular weight between 40 kDa and 68 kDa. The individ
Specificity: The antibody A53-B/A2 reacts with Rod domain of cytokeratin 19 (40 kDa) in human tissue. Cytokeratin 19 is not expressed in hepatocytes; it is often co-expressed with cytokeratin 7.Regulatory Status RUOImmunogen MCF-7 human breast adenocarcinoma cell line
Immunogen: MCF-7 human breast adenocarcinoma cell line
CAS NO: 848258-31-1
Product: Pemafibrate (racemate)
Species Reactivity: Human
Negative Species: Applications: Immunohistochemistry (paraffin sections)Flow CytometryImmunoprecipitationWestern BlottingImmunocytochemistryELISA
Applications: Immunohistochemistry (paraffin sections)Flow CytometryImmunoprecipitationWestern BlottingImmunocytochemistryELISA
PubMed ID:http://aac.asm.org/content/49/12/4867.abstract
A53-B/A2 (IgG2a)
A53-B/A2 (IgG2a)
Product Name: A53-B/A2 (IgG2a)
Background: Cytokeratins are a subfamily of intermediate filaments and characterized by remarkable biochemical diversity. Cytokeratins are represented in epithelial tissues by at least 20 different polypeptides, molecular weight between 40 kDa and 68 kDa. The individ
Specificity: The antibody A53-B/A2 reacts with Rod domain of cytokeratin 19 (40 kDa) in human tissue. Cytokeratin 19 is not expressed in hepatocytes; it is often co-expressed with cytokeratin 7.Regulatory Status RUOImmunogen MCF-7 human breast adenocarcinoma cell line
Immunogen: MCF-7 human breast adenocarcinoma cell line
CAS NO: 55837-20-2
Product: Halofuginone
Species Reactivity: Human
Negative Species: Applications: Immunohistochemistry (paraffin sections)Flow CytometryImmunoprecipitationWestern BlottingImmunocytochemistryELISA
Applications: Immunohistochemistry (paraffin sections)Flow CytometryImmunoprecipitationWestern BlottingImmunocytochemistryELISA
PubMed ID:http://aac.asm.org/content/50/9/3197.abstract